Danielle Antalffy
Stock Analyst at UBS
(3.76)
# 733
Out of 5,097 analysts
193
Total ratings
50.45%
Success rate
8.34%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Neutral | $89 → $91 | $94.55 | -3.75% | 8 | Dec 23, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $62 | $33.25 | +86.47% | 4 | Dec 12, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $90 → $92 | $86.29 | +6.62% | 13 | Dec 5, 2025 | |
| MDT Medtronic | Maintains: Neutral | $95 → $102 | $97.66 | +4.44% | 12 | Nov 19, 2025 | |
| PODD Insulet | Upgrades: Buy | $355 → $400 | $287.94 | +38.92% | 13 | Nov 19, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $6.5 → $5.85 | $2.42 | +141.74% | 8 | Nov 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $96 → $88 | $89.41 | -1.58% | 6 | Nov 6, 2025 | |
| INMD InMode | Maintains: Neutral | $16 → $16 | $14.45 | +10.76% | 5 | Nov 6, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 → $95 | $66.48 | +42.91% | 10 | Nov 3, 2025 | |
| BAX Baxter International | Maintains: Neutral | $24 → $21 | $18.68 | +12.45% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $585 → $600 | $574.34 | +4.47% | 3 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $140 | $95.87 | +46.03% | 14 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $214 | $206.36 | +3.70% | 6 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $8 | $10.74 | -25.51% | 4 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $57 | $26.44 | +115.58% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $22.83 | -25.54% | 15 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $134 | $116.68 | +14.84% | 2 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $41.36 | +40.23% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $5 | $8.80 | -43.18% | 2 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $124.75 | +18.64% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $354.07 | +4.50% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $3.93 | -42.68% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $3.42 | +24,022.81% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $32.04 | -56.30% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $67.35 | +48.48% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $16.26 | -26.20% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $36.97 | +21.72% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $195.52 | +40.65% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $5.63 | +255.56% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $6.64 | +532.53% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $60 | $6.12 | +880.38% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.72 | +1,997.02% | 1 | Sep 1, 2020 |
Inspire Medical Systems
Dec 23, 2025
Maintains: Neutral
Price Target: $89 → $91
Current: $94.55
Upside: -3.75%
PROCEPT BioRobotics
Dec 12, 2025
Initiates: Buy
Price Target: $62
Current: $33.25
Upside: +86.47%
Edwards Lifesciences
Dec 5, 2025
Maintains: Neutral
Price Target: $90 → $92
Current: $86.29
Upside: +6.62%
Medtronic
Nov 19, 2025
Maintains: Neutral
Price Target: $95 → $102
Current: $97.66
Upside: +4.44%
Insulet
Nov 19, 2025
Upgrades: Buy
Price Target: $355 → $400
Current: $287.94
Upside: +38.92%
Treace Medical Concepts
Nov 7, 2025
Maintains: Neutral
Price Target: $6.5 → $5.85
Current: $2.42
Upside: +141.74%
Zimmer Biomet Holdings
Nov 6, 2025
Maintains: Sell
Price Target: $96 → $88
Current: $89.41
Upside: -1.58%
InMode
Nov 6, 2025
Maintains: Neutral
Price Target: $16 → $16
Current: $14.45
Upside: +10.76%
DexCom
Nov 3, 2025
Maintains: Buy
Price Target: $106 → $95
Current: $66.48
Upside: +42.91%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $24 → $21
Current: $18.68
Upside: +12.45%
Oct 23, 2025
Maintains: Neutral
Price Target: $585 → $600
Current: $574.34
Upside: +4.47%
Oct 23, 2025
Maintains: Buy
Price Target: $135 → $140
Current: $95.87
Upside: +46.03%
Oct 14, 2025
Maintains: Buy
Price Target: $190 → $214
Current: $206.36
Upside: +3.70%
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $10.74
Upside: -25.51%
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $26.44
Upside: +115.58%
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $22.83
Upside: -25.54%
Jul 31, 2025
Maintains: Buy
Price Target: $125 → $134
Current: $116.68
Upside: +14.84%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $41.36
Upside: +40.23%
Jan 27, 2025
Maintains: Buy
Price Target: $5.5 → $5
Current: $8.80
Upside: -43.18%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $124.75
Upside: +18.64%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $354.07
Upside: +4.50%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $3.93
Upside: -42.68%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $3.42
Upside: +24,022.81%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $32.04
Upside: -56.30%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $67.35
Upside: +48.48%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $16.26
Upside: -26.20%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $36.97
Upside: +21.72%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $195.52
Upside: +40.65%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $5.63
Upside: +255.56%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $6.64
Upside: +532.53%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $60
Current: $6.12
Upside: +880.38%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.72
Upside: +1,997.02%